Kolexia
Nerich Virginie
Pharmacien
Hôpital Saint-Jacques de Besançon
Besançon, France
123 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs de la prostate Lymphomes Carcinomes Maladie de Hodgkin Lymphome malin non hodgkinien Néphrocarcinome Maladie chronique

Industries

Roche
6 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2022
Bayer
4 collaboration(s)
Dernière en 2020
MSD
3 collaboration(s)
Dernière en 2022

Dernières activités

French healthcare students and antibiotics: are they ready to promote their appropriate use?
JAC-antimicrobial resistance   30 décembre 2023
Patient Preferences for Pharmacy Services: A Systematic Review of Studies Based on Discrete Choice Experiments.
The patient   13 décembre 2023
ICE: Multicenter Prospective Cohort of Informal Caregivers in Burgundy-Franche-Comté. ICE Cohort (Informal Caregivers of Elderly)
Essai Clinique (CHU Besançon)   20 octobre 2023
Knowledge and perceptions of French community pharmacists and pharmacy students about the papillomavirus vaccine.
Infectious diseases now   05 octobre 2023
Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.
International journal of public health   30 août 2023
IMPLICATION: Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital: Discrete Choice Method to Inform Decision-making by Healthcare Professionals
Essai Clinique (CHU Besançon)   21 août 2023
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.
Frontiers in oncology   23 juin 2023
Pre-operative and early postoperative health-related quality of life of breast cancer woman: a Lebanese prospective study.
BMC women's health   20 avril 2023
La composante placebo des traitements de la douleur, vers une optimisation de l’efficacité
Actualites pharmaceutiques   01 février 2023
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
13th European Breast Cancer Conference (EBCC-13)   01 novembre 2022